Intercept Pharmaceuticals Inc $222.20

down -1.20


11/7/2014 04:00 PM  |  NASDAQ : ICPT  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ICPT Trend Analysis - it has outperformed the S&P 500 by 306%

Partner Headlines

  1. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  2. Benzinga's Top Initiations

    Benzinga
  3. Analysts Comment On Intercept Amid Share Decline Following FLINT Data Delay

    Benzinga
  4. Top Healthcare Movers For June 9, 2014

    Benzinga
  5. Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings

    Benzinga
  6. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., Micron Technology ...

    GuruFocus
  7. Intercept Issues Preclinical Data Showing OCA's Potential Role in Preventing ...

    Benzinga
  8. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  9. Market Wrap For March 17: Investors Focused On Economic Data Instead Of ...

    Benzinga
  10. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  11. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  12. Top Trending Tickers On StockTwits For March 17

    Benzinga
  13. Benzinga's Top #PreMarket Losers

    Benzinga
  14. Morning Gainers for Friday, March 14, 2014

    Benzinga
  15. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  16. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators Giving A ...

    Benzinga
  17. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  18. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  19. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2014?

    Benzinga
  20. Mid-Morning Market Update: Markets Rise; Bank of America Profit Beats Estimates

    Benzinga
  21. Benzinga's Top #PreMarket Gainers

    Benzinga
  22. Market Wrap For January 14: Markets Rebound On Earnings Season Kickoff

    Benzinga
  23. Mid-Afternoon Market Update: Markets Continue Rally as Tesla Guidance Lifts ...

    Benzinga
  24. Stocks Up In Afternoon; Tesla Soars On Strong Sales

    IBD
  25. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  26. Morning Market Losers

    Benzinga
  27. Benzinga's Top #PreMarket Losers

    Benzinga
  28. Intercept Reports Additional Details About FLINT Clinical Trial of OCA ...

    Benzinga
  29. Intercept to Present at the JP Morgan Healthcare Conference on Wednesday, ...

    Benzinga
  30. Market Wrap For January 10: Job Growth Weak, But Unemployment Falls

    Benzinga
  31. Mid-Afternoon Market Update: Plug Rises on Secondary Pricing as Markets ...

    Benzinga
  32. Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; Sears ...

    Benzinga
  33. Intercept Shares Skyrocket 500% This Week

    FoxBusiness
  34. Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss Estimates

    Benzinga
  35. Bank of America Reiterates on Intercept Pharmaceuticals

    Benzinga
  36. Benzinga's Volume Movers

    Benzinga
  37. Stocks Hitting 52-Week Highs

    Benzinga
  38. Citi Maintains on Intercept Pharmaceuticals

    Benzinga
  39. Stock Futures Trim Early Gains; Oriental Education Leads IBD 50

    IBD
  40. Benzinga's Top #PreMarket Gainers

    Benzinga
  41. Intercept drug hits endpoint

    IBD
  42. Mid-Afternoon Market Update: Markets Moving Sideways Ahead of Alcoa Report

    Benzinga
  43. Mid-Day Market Update: U.S. Stocks Turn Red; Bed Bath & Beyond Shares Decline ...

    Benzinga
  44. Intercept Pharma Liver-Disease Drug Scores In Trial

    IBD
  45. Benzinga's Volume Movers

    Benzinga
  46. Morning Market Movers

    Benzinga
  47. Benzinga's Top #PreMarket Gainers

    Benzinga
  48. Intercept Pharmaceutical Shares Skyrocket after Oppenheimer's Data "Optimism"

    Benzinga
  49. Intercept Prices 1.5M Share Offering at $62.50/Share

    Benzinga
  50. UPDATE: BMO Capital Markets Raises PT on Intercept Pharmaceuticals Following ...

    Benzinga
Trading Center